Biopharmas raising money in public or private financings.

Biopharmas raising money in public or private financings.

Med-tech firms raising money in public or private financings.

Med-tech firms raising money in public or private financings.

Biopharmas raising money in public or private financings.

HONG KONG – U.S.-based biotech firm Egenesis Inc., headquartered in Cambridge, Mass., has received $100 million through a series B funding round for the development of safe and effective human-compatible organs through gene editing.

Med-tech firms raising money in public or private financings.

Biopharmas raising money in public or private financings.

Biopharmas raising money in public or private financings.